Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive myopathy in hyperkalemic periodic paralysis.

W G Bradley1, R Taylor, D R Rice

  • 1Department of Neurology, University of Vermont School of Medicine, Medical Center Hospital, Burlington 05405.

Archives of Neurology
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutation Screening of Charcot-Marie-Tooth Patients in Poland.

Annals of the New York Academy of Sciences·2017
Same author

[Not Available].

Canadian family physician Medecin de famille canadien·2011
Same author

Automated system for the analysis of muscle and nerve biopsies.

Applied optics·2010
Same author

Charcot-Marie-Tooth disease type 4C4 caused by a novel Pro153Leu substitution in the GDAP1 gene.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2008
Same author

Early onset Charcot-Marie-Tooth disease caused by a homozygous Leu239Phe mutation in the GDAP1 gene.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2006
Same author

Charcot-Marie-Tooth type 4F disease caused by S399fsx410 mutation in the PRX gene.

Neurology·2006

Progressive myopathy is common in hyperkalemic periodic paralysis, similar to hypokalemic periodic paralysis. This study found significant muscle degeneration in patients with hyperkalemic periodic paralysis.

Area of Science:

  • Neurology
  • Muscle Diseases

Background:

  • Progressive myopathy is recognized in hypokalemic periodic paralysis.
  • It is less recognized in hyperkalemic periodic paralysis, despite shared genetic links.

Purpose of the Study:

  • To investigate the prevalence and characteristics of progressive myopathy in hyperkalemic periodic paralysis.
  • To compare the myopathy in hyperkalemic periodic paralysis to that seen in hypokalemic periodic paralysis.

Main Methods:

  • Studied four families with hyperkalemic periodic paralysis.
  • Analyzed clinical data, including paralysis duration and frequency.
  • Examined muscle biopsy specimens using light and electron microscopy.

Main Results:

  • Progressive myopathy developed in some family members, with prolonged paralysis episodes.

Related Experiment Videos

  • Myopathy onset often coincided with decreased paralysis attacks.
  • Biopsies revealed fiber size variability, internal nuclei, vacuoles, myofibrillary degeneration, and tubular aggregates.
  • Abnormal biopsies were more frequent in older patients.

    • Conclusions:

    • Progressive myopathy is as common in hyperkalemic periodic paralysis as in hypokalemic periodic paralysis.
    • Muscle degeneration is a significant feature of hyperkalemic periodic paralysis.
    • Age is a factor in the manifestation of myopathy in these patients.